| |
| |
|
| Insider
Information: |
Kozarich John W |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
128,523 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,871,775 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
128,523 |
|
|
| Total
Value |
$3,871,775 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -27.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-24 |
42,523 |
2006-01-04 |
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2015-06-29 |
57,000 |
2013-05-13 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
Director |
2019-05-08 |
29,000 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2014-10-15 |
4 |
B |
$45.68 |
$91,360 |
D/D |
2,000 |
49,286 |
2.39 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
12,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-19 |
4 |
B |
$3.45 |
$5,865 |
D/D |
1,700 |
13,700 |
2.39 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2014-12-22 |
4 |
B |
$3.62 |
$30,061 |
D/D |
8,300 |
22,000 |
2.39 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
925 |
50,211 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2015-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
49,711 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
32,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Director |
– • – |
2015-06-29 |
4 |
OE |
$3.30 |
$87,125 |
D/D |
25,000 |
57,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-01-20 |
4 |
OE |
$59.40 |
$98,960 |
D/D |
1,666 |
51,377 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-01-20 |
4 |
AS |
$92.71 |
$158,173 |
D/D |
(1,666) |
49,711 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-04-06 |
4 |
AS |
$115.00 |
$575,000 |
D/D |
(5,000) |
44,711 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-05-02 |
4 |
AS |
$121.45 |
$121,568 |
D/D |
(1,000) |
43,711 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2016-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
22,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
350 |
43,361 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
622 |
44,333 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-06-01 |
4 |
AS |
$117.19 |
$117,419 |
D/D |
(1,000) |
42,983 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-07-01 |
4 |
AS |
$119.47 |
$121,402 |
D/D |
(1,000) |
41,983 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-08-01 |
4 |
AS |
$135.78 |
$137,569 |
D/D |
(1,000) |
40,983 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-09-01 |
4 |
AS |
$103.59 |
$175,597 |
D/D |
(1,666) |
39,317 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-09-01 |
4/A |
OE |
$45.60 |
$75,970 |
D/D |
1,666 |
40,983 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2016-09-07 |
4 |
AS |
$115.00 |
$115,000 |
D/D |
(1,000) |
39,983 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
24,500 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
666 |
40,649 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-11-16 |
4 |
S |
$141.71 |
$708,550 |
D/D |
(5,000) |
35,649 |
0 |
- |
|
74 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
